• |
  • |
  • |
  • |
Donate

Product

Impact of In Utero Opioid Exposure on Newborn Outcomes: Beyond Neonatal Opioid Withdrawal Syndrome

Center:
Fiscal Year:
2022
Contact Information:
Product Description:
Our goal was to compare birth outcomes between newborns with prenatal opioid exposure and a matched control group. Participants were identified over five years within a regional health system (6 delivery hospitals across 2 states). From 18,000 births, 300 with prenatal opioid exposure and 300 control newborns matched on exposure, medical, and background factors were included. Outcomes included pregnancy/delivery complications, newborn size, and newborn health complications
Keyword(s):
pregnancy substance use, opioid exposure, newborn outcomes
Product/Publication Type(s):
Doctoral Dissertation or Master's Thesis
Target Audience:
Professionals
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A